In Compliance with Regulation 74(5) of SEBl (Depositories and Participants) Regulations, 2018, Jagsonpal Pharmaceuticals has informed that it has enclosed a copy of the Certificate received from MCS Share Transfer Agent, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th June, 2019.
The above information is a part of company’s filings submitted to BSE.